Shopping Cart 0
Cart Subtotal
USD 0

Elite Pharmaceuticals Inc (ELTP) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Elite Pharmaceuticals Inc (ELTP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company focuses on the development of oral sustained and controlled release drug products. The company manufactures and develops generic drugs upon marketing approvals via Abbreviated New Drug Applications (ANDA) and branded drugs via New Drug Application (NDA) for the treatment of pain, obesity, hypertension, depression, infection and allergy, among others. Elite also has a pipeline of abuse-deterrent opioids for the treatment of chronic pain. The company uses its proprietary ART (abuse-deterrent technology) platform to develop and manufacture oral, controlled-release drugs. Elite is headquartered in Northvale, New Jersey, the US.

Elite Pharmaceuticals Inc Key Recent Developments

Feb 11,2019: Elite pharmaceuticals reports financial results for the third quarter of fiscal year 2019 ended December 31, 2018 and provides conference call information

Nov 09,2018: Elite Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information

Oct 24,2018: Elite Pharmaceuticals reports positive results from a pivotal bioequivalence study

Aug 09,2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018

Aug 07,2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Elite Pharmaceuticals Inc-Key Facts

Elite Pharmaceuticals Inc-Key Employees

Elite Pharmaceuticals Inc-Key Employee Biographies

Elite Pharmaceuticals Inc-Major Products and Services

Elite Pharmaceuticals Inc-History

Elite Pharmaceuticals Inc-Company Statement

Elite Pharmaceuticals Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Elite Pharmaceuticals Inc-Business Description

Business Segment: Branded Pharmaceuticals (NDA segment)

Overview

Performance

Business Segment: Generic Pharmaceuticals (ANDA segment)

Overview

Performance

Elite Pharmaceuticals Inc-Corporate Strategy

Elite Pharmaceuticals Inc-SWOT Analysis

SWOT Analysis-Overview

Elite Pharmaceuticals Inc-Strengths

Elite Pharmaceuticals Inc-Weaknesses

Elite Pharmaceuticals Inc-Opportunities

Elite Pharmaceuticals Inc-Threats

Elite Pharmaceuticals Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Elite Pharmaceuticals Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 11, 2019: Elite pharmaceuticals reports financial results for the third quarter of fiscal year 2019 ended December 31, 2018 and provides conference call information

Nov 09, 2018: Elite Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information

Oct 24, 2018: Elite Pharmaceuticals reports positive results from a pivotal bioequivalence study

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018

Aug 07, 2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors

Jun 14, 2018: Elite Pharmaceuticals Announces Financial Results for the Fiscal Year Ended March 31, 2018

Feb 09, 2018: Elite Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017

Jan 10, 2018: Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Elite Pharmaceuticals Inc, Performance Chart (2015-2019)

Elite Pharmaceuticals Inc, Ratio Charts

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Elite Pharmaceuticals Inc, Key Facts

Elite Pharmaceuticals Inc, Key Employees

Elite Pharmaceuticals Inc, Key Employee Biographies

Elite Pharmaceuticals Inc, Major Products and Services

Elite Pharmaceuticals Inc, History

Elite Pharmaceuticals Inc, Subsidiaries

Elite Pharmaceuticals Inc, Key Competitors

Elite Pharmaceuticals Inc, Ratios based on current share price

Elite Pharmaceuticals Inc, Annual Ratios

Elite Pharmaceuticals Inc, Annual Ratios (Cont...1)

Elite Pharmaceuticals Inc, Interim Ratios

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Elite Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Elite Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Endo Pharmaceuticals Inc

Purdue Pharma LP

Mylan Laboratories Ltd

Collegium Pharmaceutical Inc

Sandoz Inc

Acura Pharmaceuticals Inc

Mallinckrodt LLC

Company Profile

Company Profile Title

Elite Pharmaceuticals Inc (ELTP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company focuses on the development of oral sustained and controlled release drug products. The company manufactures and develops generic drugs upon marketing approvals via Abbreviated New Drug Applications (ANDA) and branded drugs via New Drug Application (NDA) for the treatment of pain, obesity, hypertension, depression, infection and allergy, among others. Elite also has a pipeline of abuse-deterrent opioids for the treatment of chronic pain. The company uses its proprietary ART (abuse-deterrent technology) platform to develop and manufacture oral, controlled-release drugs. Elite is headquartered in Northvale, New Jersey, the US.

Elite Pharmaceuticals Inc Key Recent Developments

Feb 11,2019: Elite pharmaceuticals reports financial results for the third quarter of fiscal year 2019 ended December 31, 2018 and provides conference call information

Nov 09,2018: Elite Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information

Oct 24,2018: Elite Pharmaceuticals reports positive results from a pivotal bioequivalence study

Aug 09,2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018

Aug 07,2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Elite Pharmaceuticals Inc-Key Facts

Elite Pharmaceuticals Inc-Key Employees

Elite Pharmaceuticals Inc-Key Employee Biographies

Elite Pharmaceuticals Inc-Major Products and Services

Elite Pharmaceuticals Inc-History

Elite Pharmaceuticals Inc-Company Statement

Elite Pharmaceuticals Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Elite Pharmaceuticals Inc-Business Description

Business Segment: Branded Pharmaceuticals (NDA segment)

Overview

Performance

Business Segment: Generic Pharmaceuticals (ANDA segment)

Overview

Performance

Elite Pharmaceuticals Inc-Corporate Strategy

Elite Pharmaceuticals Inc-SWOT Analysis

SWOT Analysis-Overview

Elite Pharmaceuticals Inc-Strengths

Elite Pharmaceuticals Inc-Weaknesses

Elite Pharmaceuticals Inc-Opportunities

Elite Pharmaceuticals Inc-Threats

Elite Pharmaceuticals Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Elite Pharmaceuticals Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 11, 2019: Elite pharmaceuticals reports financial results for the third quarter of fiscal year 2019 ended December 31, 2018 and provides conference call information

Nov 09, 2018: Elite Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information

Oct 24, 2018: Elite Pharmaceuticals reports positive results from a pivotal bioequivalence study

Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018

Aug 07, 2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors

Jun 14, 2018: Elite Pharmaceuticals Announces Financial Results for the Fiscal Year Ended March 31, 2018

Feb 09, 2018: Elite Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017

Jan 10, 2018: Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Elite Pharmaceuticals Inc, Performance Chart (2015-2019)

Elite Pharmaceuticals Inc, Ratio Charts

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Elite Pharmaceuticals Inc, Key Facts

Elite Pharmaceuticals Inc, Key Employees

Elite Pharmaceuticals Inc, Key Employee Biographies

Elite Pharmaceuticals Inc, Major Products and Services

Elite Pharmaceuticals Inc, History

Elite Pharmaceuticals Inc, Subsidiaries

Elite Pharmaceuticals Inc, Key Competitors

Elite Pharmaceuticals Inc, Ratios based on current share price

Elite Pharmaceuticals Inc, Annual Ratios

Elite Pharmaceuticals Inc, Annual Ratios (Cont...1)

Elite Pharmaceuticals Inc, Interim Ratios

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Elite Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Elite Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Endo Pharmaceuticals Inc

Purdue Pharma LP

Mylan Laboratories Ltd

Collegium Pharmaceutical Inc

Sandoz Inc

Acura Pharmaceuticals Inc

Mallinckrodt LLC